Assessing the gold standard—lessons from the history of RCTs LE Bothwell, JA Greene, SH Podolsky, DS Jones N engl j med 374 (22), 2175-2181, 2016 | 691 | 2016 |
The emergence of the randomized, controlled trial LE Bothwell, SH Podolsky The New England journal of medicine 375 (6), 501-504, 2016 | 201 | 2016 |
Adaptive design clinical trials: a review of the literature and ClinicalTrials. gov LE Bothwell, J Avorn, NF Khan, AS Kesselheim BMJ open 8 (2), e018320, 2018 | 188 | 2018 |
The Real‐World Ethics of Adaptive‐Design Clinical Trials LE Bothwell, AS Kesselheim Hastings Center Report 47 (6), 27-37, 2017 | 27 | 2017 |
Innovation and tribulation in the history of randomized controlled trials in surgery LE Bothwell, DS Jones Annals of surgery 274 (6), e616-e624, 2021 | 13 | 2021 |
The emergence of the randomized controlled trial: origins to 1980 L Bothwell Columbia University, 2014 | 12 | 2014 |
Adaptive design clinical trials: a review of the literature and ClinicalTrials. gov. BMJ Open. 2018; 8: e018320 LE Bothwell, J Avorn, NF Khan, AS Kesselheim | 11 | |
Social and scientific history of randomized controlled trials LE Bothwell, WH Kuo, DS Jones, SH Podolsky Principles and practice of clinical trials, 3-19, 2022 | 2 | 2022 |
Bioethical issues in pharmacoepidemiologic research LE Bothwell, A Richterich, JA Greene Pharmacoepidemiology, 772-791, 2019 | | 2019 |
How Do Adaptive Design Clinical Trials Compare to Standard Randomized Controlled Trials in Evaluating New Therapeutic Interventions? L Bothwell, J Avorn, N Khan, A Kesselheim 2016 Annual Research Meeting, 2016 | | 2016 |
Systematic Review of Adaptive Design Clinical Trials L Bothwell, N Khan, A Kesselheim PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 24, 583-584, 2015 | | 2015 |
Published Ahead-of-Print-Last Updated: October 22, 2019 LE Bothwell, DS Jones | | |